BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29083322)

  • 1. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.
    Toischer K; Zhu W; Hünlich M; Mohamed BA; Khadjeh S; Reuter SP; Schäfer K; Ramanujam D; Engelhardt S; Field LJ; Hasenfuss G
    J Clin Invest; 2017 Dec; 127(12):4285-4296. PubMed ID: 29083322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
    Zhu W; Reuter S; Field LJ
    Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic stress-induced cardiac remodelling is not modulated by ablation of phosphodiesterase 4D interacting protein.
    Mohamed BA; Elkenani M; Mobarak S; Marques Rodrigues D; Annamalai K; Schnelle M; Bader M; Hasenfuss G; Toischer K
    J Cell Mol Med; 2022 Aug; 26(16):4440-4452. PubMed ID: 35860864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
    Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
    J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
    Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
    Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
    Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
    PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein receptor-related protein 6 regulates cardiomyocyte-derived paracrine signaling to ameliorate cardiac fibrosis.
    Wang X; Zou Y; Chen Z; Li Y; Pan L; Wang Y; Liu M; Yin C; Wu J; Yang C; Zhang L; Li C; Huang Z; Wang D; Qian J; Ge J; Zou Y; Gong H
    Theranostics; 2021; 11(3):1249-1268. PubMed ID: 33391533
    [No Abstract]   [Full Text] [Related]  

  • 10. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
    Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte d-dopachrome tautomerase protects against heart failure.
    Ma Y; Su KN; Pfau D; Rao VS; Wu X; Hu X; Leng L; Du X; Piecychna M; Bedi K; Campbell SG; Eichmann A; Testani JM; Margulies KB; Bucala R; Young LH
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox regulation of cardiomyocyte cell cycling via an ERK1/2 and c-Myc-dependent activation of cyclin D2 transcription.
    Murray TV; Smyrnias I; Schnelle M; Mistry RK; Zhang M; Beretta M; Martin D; Anilkumar N; de Silva SM; Shah AM; Brewer AC
    J Mol Cell Cardiol; 2015 Feb; 79():54-68. PubMed ID: 25450615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Cycle-Mediated Cardiac Regeneration in the Mouse Heart.
    Eghbali A; Dukes A; Toischer K; Hasenfuss G; Field LJ
    Curr Cardiol Rep; 2019 Sep; 21(10):131. PubMed ID: 31529165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. βIV-Spectrin regulates STAT3 targeting to tune cardiac response to pressure overload.
    Unudurthi SD; Nassal D; Greer-Short A; Patel N; Howard T; Xu X; Onal B; Satroplus T; Hong D; Lane C; Dalic A; Koenig SN; Lehnig AC; Baer LA; Musa H; Stanford KI; Smith S; Mohler PJ; Hund TJ
    J Clin Invest; 2018 Dec; 128(12):5561-5572. PubMed ID: 30226828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.
    Jochmann S; Elkenani M; Mohamed BA; Buchholz E; Lbik D; Binder L; Lorenz K; Shah AM; Hasenfuß G; Toischer K; Schnelle M
    ESC Heart Fail; 2019 Oct; 6(5):1015-1026. PubMed ID: 31322843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cardiac remodeling in preload versus afterload.
    Toischer K; Rokita AG; Unsöld B; Zhu W; Kararigas G; Sossalla S; Reuter SP; Becker A; Teucher N; Seidler T; Grebe C; Preuss L; Gupta SN; Schmidt K; Lehnart SE; Krüger M; Linke WA; Backs J; Regitz-Zagrosek V; Schäfer K; Field LJ; Maier LS; Hasenfuss G
    Circulation; 2010 Sep; 122(10):993-1003. PubMed ID: 20733099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
    Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
    Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.